| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Nicola C Partridge | Q55835077 |
| P2093 | author name string | Liza J Raggatt | |
| P2860 | cites work | Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1 | Q24300916 |
| Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 | ||
| Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
| Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist | Q24646652 | ||
| Osteoimmunology: interactions of the bone and immune system | Q24655113 | ||
| Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development | Q28119185 | ||
| The microphthalmia transcription factor regulates expression of the tartrate-resistant acid phosphatase gene during terminal differentiation of osteoclasts | Q28140929 | ||
| Bone resorption by osteoclasts | Q28145169 | ||
| Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: complementary roles in bone remodeling regulation? | Q28217341 | ||
| Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling | Q28240767 | ||
| Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin | Q28261537 | ||
| Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2 | Q28585601 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts | Q29547605 | ||
| Genetic regulation of osteoclast development and function | Q29617421 | ||
| Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts | Q29618116 | ||
| A physical mechanism for coupling bone resorption and formation in adult human bone. | Q30485638 | ||
| A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy | Q30653079 | ||
| A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide | Q31035948 | ||
| The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. | Q33823576 | ||
| Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts | Q33939357 | ||
| Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. | Q34508386 | ||
| Transcriptional control of skeletogenesis | Q34820209 | ||
| Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders | Q35097443 | ||
| Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation | Q35210378 | ||
| B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo | Q35804512 | ||
| Osteoclast-derived activity in the coupling of bone formation to resorption. | Q36032429 | ||
| Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors | Q36375584 | ||
| Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice | Q36791739 | ||
| Dissociation between bone resorption and bone formation in osteopenic transgenic mice | Q36800774 | ||
| Osteocytes as dynamic multifunctional cells | Q36889712 | ||
| Osteitis fibrosa is mediated by Platelet-Derived Growth Factor-A via a phosphoinositide 3-kinase-dependent signaling pathway in a rat model for chronic hyperparathyroidism | Q36976360 | ||
| Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate. | Q37015968 | ||
| T cells: unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis | Q37033722 | ||
| Identification of cell cycle-arrested quiescent osteoclast precursors in vivo | Q37124343 | ||
| Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability | Q37261160 | ||
| Osteal macrophages: a new twist on coupling during bone dynamics | Q37286721 | ||
| TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation | Q37307155 | ||
| Differentiation and heterogeneity in the mononuclear phagocyte system | Q37349749 | ||
| Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts | Q37374745 | ||
| Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts | Q40095819 | ||
| Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: enhancement by estrogen | Q40744910 | ||
| The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated | Q40838648 | ||
| Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. | Q41121255 | ||
| A three-dimensional ultrastructural study of osteoid-osteocytes in the tibia of chick embryos. | Q41476335 | ||
| The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. | Q41649459 | ||
| Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors | Q41842422 | ||
| Hormonal regulation of the production of collagenase and a collagenase inhibitor activity by rat osteogenic sarcoma cells | Q42509736 | ||
| Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone | Q42732135 | ||
| Mechanical strain induces collagenase-3 (MMP-13) expression in MC3T3-E1 osteoblastic cells | Q42830345 | ||
| The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation. | Q43842252 | ||
| Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo | Q46277067 | ||
| Osteopontin is strongly expressed by alveolar macrophages in the lungs of acute respiratory distress syndrome | Q47900564 | ||
| Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. | Q53628612 | ||
| PTH/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats. | Q54156212 | ||
| Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis | Q57675131 | ||
| c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling | Q58326943 | ||
| The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
| Macrophages in T and B cell compartments and other tissue macrophages recognized by monoclonal antibody MOMA-2. An immunohistochemical study | Q68215594 | ||
| An electron-microscopic study of the bone-remodeling sequence in the rat | Q70424503 | ||
| Alkaline phosphatase expression during monocyte differentiation. Overlapping markers as a link between monocytic cells, dendritic cells, osteoclasts and osteoblasts | Q73952564 | ||
| Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation | Q74411385 | ||
| Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers | Q74488802 | ||
| Identification of multiple osteoclast precursor populations in murine bone marrow | Q81628327 | ||
| P433 | issue | 33 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 25103-25108 | |
| P577 | publication date | 2010-05-25 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Cellular and molecular mechanisms of bone remodeling | |
| P478 | volume | 285 |
| Q92861301 | 15-Deoxy-Δ12,14-prostaglandin J2 as a potential regulator of bone metabolism via PPARγ-dependent and independent pathways: a review |
| Q64107402 | A Novel Small Molecule Which Increases Osteoprotegerin Expression and Protects Against Ovariectomy-Related Bone Loss in Rats |
| Q37598104 | A Review on the Relationship between Aspirin and Bone Health |
| Q38986443 | A Sclerostin super-producer cell line derived from the human cell line SaOS-2: a new tool for the study of the molecular mechanisms driving Sclerostin expression. |
| Q42007592 | A T Cell View of the Bone Marrow |
| Q28066891 | A concise review of testosterone and bone health |
| Q37912798 | A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide's potential role in its resolution |
| Q57052546 | A multiscale model to predict current absolute risk of femoral fracture in a postmenopausal population |
| Q92141967 | A new biological bone remodeling in silico model combined with advanced discretization methods |
| Q34197280 | A novel library screen identifies immunosuppressors that promote osteoblast differentiation |
| Q41683535 | AFF1 and AFF4 differentially regulate the osteogenic differentiation of human MSCs |
| Q37090080 | Acute and Stress-related Injuries of Bone and Cartilage: Pertinent Anatomy, Basic Biomechanics, and Imaging Perspective |
| Q37256441 | Adenosine A2B receptors play an important role in bone homeostasis. |
| Q91675874 | Adult Stem Cells for Bone Regeneration and Repair |
| Q34597741 | Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases |
| Q37673302 | Age-Related Loss in Bone Mineral Density of Rats Fed Lifelong on a Fish Oil-Based Diet Is Avoided by Coenzyme Q10 Addition. |
| Q36685210 | Aged male rats regenerate cortical bone with reduced osteocyte density and reduced secretion of nitric oxide after mechanical stimulation |
| Q34160511 | Aging, human immunodeficiency virus, and bone health |
| Q57816163 | All-trans retinoic acid can antagonize osteoblastogenesis induced by different BMPs irrespective of their dimerization types and dose-efficiencies |
| Q34430802 | Alterations in bone and erythropoiesis in hemolytic anemia: comparative study in bled, phenylhydrazine-treated and Plasmodium-infected mice |
| Q58994796 | Amelogenin Peptide Extract Increases Differentiation and Angiogenic and Local Factor Production and Inhibits Apoptosis in Human Osteoblasts |
| Q47127976 | An Essential Physiological Role for MCT8 in Bone in Male Mice |
| Q59142520 | An Overview of Biomaterials in Periodontology and Implant Dentistry |
| Q92589976 | Anti-Osteoporotic Effects of Kukoamine B Isolated from Lycii Radicis Cortex Extract on Osteoblast and Osteoclast Cells and Ovariectomized Osteoporosis Model Mice |
| Q47166692 | Artemisia annua extract prevents ovariectomy-induced bone loss by blocking receptor activator of nuclear factor kappa-B ligand-induced differentiation of osteoclasts |
| Q37409308 | Association between osteocalcin and cognitive performance in healthy older adults. |
| Q40245049 | Associations of 24-hour sleep duration and CT-derived measurements of muscle and bone: The AGES-Reykjavik Study |
| Q36315765 | Augmented LPS responsiveness in type 1 diabetes-derived osteoclasts |
| Q35852850 | Autophagy in osteoblasts is involved in mineralization and bone homeostasis |
| Q47129742 | BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation |
| Q40102980 | Bio-implant as a novel restoration for tooth loss |
| Q55384033 | Bioceramics and bone healing. |
| Q47559348 | Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: Implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin-mediated osteoblastogenesis. |
| Q35323590 | Biological strategies for improved osseointegration and osteoinduction of porous metal orthopedic implants |
| Q38316291 | Biologically inspired dynamic material systems |
| Q37924117 | Bisphosphonates as radionuclide carriers for imaging or systemic therapy. |
| Q36424174 | Bone Anabolic Effects of Soluble Si: In Vitro Studies with Human Mesenchymal Stem Cells and CD14+ Osteoclast Precursors. |
| Q28066397 | Bone Cells Dynamics during Peri-Implantitis: a Theoretical Analysis |
| Q64236083 | Bone Sialoprotein Shows Enhanced Expression in Early, High-Proliferation Stages of Three-Dimensional Spheroid Cell Cultures of Breast Cancer Cell Line MDA-MB-231 |
| Q46289896 | Bone marrow stromal cells from aged male rats have delayed mineralization and reduced response to mechanical stimulation through nitric oxide and ERK1/2 signaling during osteogenic differentiation |
| Q91813749 | Bone physiology as inspiration for tissue regenerative therapies |
| Q51842636 | Bone production by human maxillary sinus mucosa cells. |
| Q48003981 | Bone remodeling as a spatial evolutionary game |
| Q39168502 | Bone turnover markers in sheep and goat: A review of the scientific literature. |
| Q35592362 | Bone-immune cell crosstalk: bone diseases. |
| Q35138925 | Bone-remodeling transcript levels are independent of perching in end-of-lay white leghorn chickens |
| Q48241012 | Bre Enhances Osteoblastic Differentiation by Promoting the Mdm2-Mediated Degradation of p53. |
| Q38771403 | CD169(+) macrophages mediate pathological formation of woven bone in skeletal lesions of prostate cancer |
| Q33567830 | Can denosumab be a substitute, competitor, or complement to bisphosphonates? |
| Q38493236 | Cancer-associated muscle weakness: What's bone got to do with it? |
| Q27325791 | Cartilage-specific deletion of ephrin-B2 in mice results in early developmental defects and an osteoarthritis-like phenotype during aging in vivo |
| Q36723297 | Cathepsin L inactivation leads to multimodal inhibition of prostate cancer cell dissemination in a preclinical bone metastasis model. |
| Q36218199 | Cathepsin L targeting in cancer treatment. |
| Q39387130 | Cellularizing hydrogel-based scaffolds to repair bone tissue: How to create a physiologically relevant micro-environment? |
| Q34077850 | Characterization of the response of primary cells relevant to dialysis-related amyloidosis to β2-microglobulin monomer and fibrils |
| Q39139785 | Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis |
| Q51402738 | Chemokine-Like Receptor 1 Is a Novel Wnt Target Gene that Regulates Mesenchymal Stem Cell Differentiation. |
| Q92511368 | Chronic Implant-Related Bone Infections-Can Immune Modulation be a Therapeutic Strategy? |
| Q40027857 | Circadian Clock Regulates Bone Resorption in Mice |
| Q64088999 | Clinical Application of Bone Turnover Markers in Osteoporosis in Korea |
| Q41115921 | Combination of alendronate and genistein synergistically suppresses osteoclastic differentiation of RAW267.4 cells in vitro |
| Q33829044 | Comparative in vitro study regarding the biocompatibility of titanium-base composites infiltrated with hydroxyapatite or silicatitanate |
| Q50528600 | Comparison between inflammation-related markers in peri-implant crevicular fluid and clinical parameters during osseointegration in edentulous jaws. |
| Q98945602 | Compounds isolated from Euonymus spraguei Hayata induce ossification through multiple pathways |
| Q36510130 | Congenic mice provide in vivo evidence for a genetic locus that modulates intrinsic transforming growth factor β1-mediated signaling and bone acquisition |
| Q58792813 | Costimulation of Murine Osteoblasts with Interferon- and Tumor Necrosis Factor- Induces Apoptosis through Downregulation of Bcl-2 and Release of Cytochrome from Mitochondria |
| Q50506351 | Coupling factors and exosomal packaging microRNAs involved in the regulation of bone remodelling. |
| Q38938523 | Curcumin analog UBS109 prevents bone marrow osteoblastogenesis and osteoclastogenesis disordered by coculture with breast cancer MDA-MB-231 bone metastatic cells in vitro |
| Q36303922 | Curcumin increases rat mesenchymal stem cell osteoblast differentiation but inhibits adipocyte differentiation |
| Q59615333 | Current Challenges in Bone Biology |
| Q51698912 | DGKζ Downregulation Enhances Osteoclast Differentiation and Bone Resorption Activity Under Inflammatory Conditions. |
| Q64107854 | DNMT and HDAC inhibitors modulate MMP-9-dependent H3 N-terminal tail proteolysis and osteoclastogenesis |
| Q110668592 | Damaged armour: Ichnotaxonomy and paleoparasitology of bioerosion lesions in osteoderms of Quaternary extinct armadillos |
| Q37557163 | Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II. |
| Q48109354 | Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption. |
| Q36610276 | Deletion of the membrane complement inhibitor CD59a drives age and gender-dependent alterations to bone phenotype in mice. |
| Q37706364 | Deregulation of bone forming cells in bone diseases and anabolic effects of strontium-containing agents and biomaterials |
| Q47191019 | Different compact hybrid Langmuir-Blodgett-film coatings modify biomineralization and the ability of osteoblasts to grow |
| Q30415395 | Differential roles of MAPK kinases MKK3 and MKK6 in osteoclastogenesis and bone loss |
| Q47214335 | Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity |
| Q30438714 | Disrupted bone remodeling leads to cochlear overgrowth and hearing loss in a mouse model of fibrous dysplasia |
| Q35129460 | Distinct actions of akt1 on skeletal architecture and function |
| Q99710896 | Distinguish fatty acids impact survival, differentiation and cellular function of periodontal ligament fibroblasts |
| Q36055881 | Do epigenetic marks govern bone mass and homeostasis? |
| Q91921619 | Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption? |
| Q35846972 | Dynamic fluid flow induced mechanobiological modulation of in situ osteocyte calcium oscillations |
| Q64900719 | Early-Life Cadmium Exposure and Bone-Related Biomarkers: A Longitudinal Study in Children. |
| Q42560554 | Editorial: is it time for an evolutionarily based human endocrinology? |
| Q89510785 | Effect of Nano-Montmorillonite on Osteoblast Differentiation, Mineral Density, and Osteoclast Differentiation in Bone Formation |
| Q88104598 | Effect of remifentanil on pre-osteoclast cell differentiation in vitro |
| Q34501008 | Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression |
| Q38744409 | Effects of Dihydrophaseic Acid 3'-O-β-d-Glucopyranoside Isolated from Lycii radicis Cortex on Osteoblast Differentiation |
| Q38895141 | Effects of Glucosinolates from Turnip (Brassica rapa L.) Root on Bone Formation by Human Osteoblast-Like MG-63 Cells and in Normal Young Rats |
| Q40076500 | Effects of Tribulus terrestris on monosodium iodoacetate‑induced osteoarthritis pain in rats |
| Q57778349 | Electrical stimulation of human mesenchymal stem cells on biomineralized conducting polymers enhances their differentiation towards osteogenic outcomes |
| Q53141245 | Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. |
| Q45948743 | Elevated Response to Type I IFN Enhances RANKL-Mediated Osteoclastogenesis in Usp18-Knockout Mice. |
| Q35276368 | Elevation of extracellular Ca2+ induces store-operated calcium entry via calcium-sensing receptors: a pathway contributes to the proliferation of osteoblasts |
| Q36655566 | Endocrine osteoporosis: report of a series of cases |
| Q47405139 | Engineered Paper-Based Cell Culture Platforms |
| Q33838933 | Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients |
| Q89491150 | Evaluation of Neo-Osteogenesis in Eosinophilic Chronic Rhinosinusitis Using a Nasal Polyp Murine Model |
| Q30985610 | Evaluation of bone remodeling around single dental implants of different lengths: a mechanobiological numerical simulation and validation using clinical data. |
| Q59790416 | Exosomes-the enigmatic regulators of bone homeostasis |
| Q90407419 | Exosomes: mediators of bone diseases, protection, and therapeutics potential |
| Q38726181 | Experimental studies of bone mechanoadaptation: bridging in vitro and in vivo studies with multiscale systems |
| Q52779703 | Expression of typical osteoclast markers by PBMCs after PEG-induced fusion as a model for studying osteoclast differentiation. |
| Q34232152 | Extracellular Microfibrils Control Osteoblast-supported Osteoclastogenesis by Restricting TGFβ Stimulation of RANKL Production |
| Q90745020 | F2r negatively regulates osteoclastogenesis through inhibiting the Akt and NFκB signaling pathways |
| Q92989114 | Fermented Oyster Extract Prevents Ovariectomy-Induced Bone Loss and Suppresses Osteoclastogenesis |
| Q38541335 | Focus on the p38 MAPK signaling pathway in bone development and maintenance |
| Q38893973 | Function and regulation of microRNA-31 in development and disease. |
| Q28822341 | Functional droplets that recognize, collect, and transport debris on surfaces |
| Q64105674 | G-protein Gα functions as a cytoskeletal and mitochondrial regulator to restrain osteoclast function |
| Q37282297 | GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation |
| Q53184425 | Genetic backgrounds and redox conditions influence morphological characteristics and cell differentiation of osteoclasts in mice. |
| Q38723595 | Ginsenoside Re Promotes Osteoblast Differentiation in Mouse Osteoblast Precursor MC3T3-E1 Cells and a Zebrafish Model. |
| Q38894222 | Gliotoxin potentiates osteoblast differentiation by inhibiting nuclear factor-κB signaling |
| Q55359481 | H3K27me1 is essential for MMP-9-dependent H3N-terminal tail proteolysis during osteoclastogenesis. |
| Q26777956 | High Cholesterol Deteriorates Bone Health: New Insights into Molecular Mechanisms |
| Q90397024 | How Physical Activity across the Lifespan Can Reduce the Impact of Bone Ageing: A Literature Review |
| Q92624408 | Human Bone Marrow-Derived Mesenchymal Stromal Cell-Seeded Bone Biomaterial Directs Fast and Superior Mandibular Bone Augmentation in Rats |
| Q37238209 | Hyperglycemia induced and intrinsic alterations in type 2 diabetes-derived osteoclast function |
| Q55121772 | IL-20 bone diseases involvement and therapeutic target potential. |
| Q90649755 | Identification of Five Novel Mutations Causing Rare Lysosomal Storage Diseases |
| Q64264178 | Identification of Genes Differentially Expressed in Simvastatin-Induced Alveolar Bone Formation |
| Q35062847 | Identification of hydroxyapatite spherules provides new insight into subretinal pigment epithelial deposit formation in the aging eye |
| Q37524529 | Immune response associated with Toll-like receptor 4 signaling pathway leads to steroid-induced femoral head osteonecrosis |
| Q38203944 | Immunomodulation regulates mesenchymal stem cell-based bone regeneration |
| Q38078839 | Impact of diabetes and its treatments on skeletal diseases |
| Q48143719 | Improved expression of Sirt1 on thymic epithelial cells of SAMP10 after Intrabone marrow-bone marrow transplantation |
| Q92643262 | In vitro bone-like nodules generated from patient-derived iPSCs recapitulate pathological bone phenotypes |
| Q40310173 | In vitro osteogenic and odontogenic differentiation of human dental pulp stem cells seeded on carboxymethyl cellulose-hydroxyapatite hybrid hydrogel |
| Q51308225 | Inactivation of Regulatory-associated Protein of mTOR (Raptor)/Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice. |
| Q40851525 | Increased NF-κB Activity and Decreased Wnt/β-Catenin Signaling Mediate Reduced Osteoblast Differentiation and Function in ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mice |
| Q35817953 | Influence of duty cycle on the time course of muscle fatigue and the onset of neuromuscular compensation during exhaustive dynamic isolated limb exercise |
| Q38766630 | Influence of olive oil on alveolar bone response during orthodontic retention period: rabbit model study |
| Q57086312 | Interferon Gamma Inhibits Adipogenesis In Vitro and Prevents Marrow Fat Infiltration in Oophorectomized Mice |
| Q47097021 | Is osteoporosis an autoimmune mediated disorder? |
| Q38796460 | Knockdown of TNFR1 Suppresses Expression of TLR2 in the Cellular Response to Staphylococcus aureus Infection. |
| Q90002263 | LMCD1 promotes osteogenic differentiation of human bone marrow stem cells by regulating BMP signaling |
| Q91813790 | Lactate and cancer: spinal metastases and potential therapeutic targets (part 2) |
| Q55337209 | Lights and shadows of NSAIDs in bone healing: the role of prostaglandins in bone metabolism. |
| Q54614405 | Local gene transfer of OPG prevents joint damage and disease progression in collagen-induced arthritis. |
| Q89977149 | METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export |
| Q38895940 | Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer |
| Q37622547 | Mechanism and function of monoclonal antibodies targeting siglec-15 for therapeutic inhibition of osteoclastic bone resorption |
| Q38742594 | Mechanosensor polycystin-1 potentiates differentiation of human osteoblastic cells by upregulating Runx2 expression via induction of JAK2/STAT3 signaling axis. |
| Q30430989 | Mechanotransduction in musculoskeletal tissue regeneration: effects of fluid flow, loading, and cellular-molecular pathways. |
| Q51718842 | Melatonin reversed tumor necrosis factor-alpha-inhibited osteogenesis of human mesenchymal stem cells by stabilizing SMAD1 protein. |
| Q36994689 | Membrane trafficking in osteoblasts and osteoclasts: new avenues for understanding and treating skeletal diseases |
| Q39039255 | Mesenchymal stem cells in the aseptic loosening of total joint replacements |
| Q37077751 | Metabolic and clinical consequences of hyperthyroidism on bone density |
| Q37729189 | Methyl Gallate Inhibits Osteoclast Formation and Function by Suppressing Akt and Btk-PLCγ2-Ca2+ Signaling and Prevents Lipopolysaccharide-Induced Bone Loss. |
| Q34700233 | Microgravity induces pelvic bone loss through osteoclastic activity, osteocytic osteolysis, and osteoblastic cell cycle inhibition by CDKN1a/p21. |
| Q57988929 | Mild hydrostatic pressure triggers oxidative responses in Escherichia coli |
| Q35106118 | Modeling TGF-β in early stages of cancer tissue dynamics. |
| Q34457215 | Modelling osteomyelitis |
| Q58572612 | Models of Bone Remodelling and Associated Disorders |
| Q34533989 | Models of ex vivo explant cultures: applications in bone research |
| Q92989218 | Modulation of Bone and Marrow Niche by Cholesterol |
| Q55111648 | Modulation of Osteoclast Interactions with Orthopaedic Biomaterials. |
| Q92510950 | Modulatory Effects of Plant Polyphenols on Bone Remodeling: A Prospective View From the Bench to Bedside |
| Q47230461 | Molecular Adjuvants Based On Plasmids Encoding Protein Aggregation Domains Affect Bone Marrow Niche Homeostasis. |
| Q53717160 | Molecular markers of dental pulp tissue during orthodontic tooth movement: a pilot study. |
| Q33758508 | Molecular mechanisms of bone metastasis and associated muscle weakness |
| Q57794000 | Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies |
| Q42226833 | NFATC1 promotes epicardium-derived cell invasion into myocardium |
| Q59130214 | NUMB maintains bone mass by promoting degradation of PTEN and GLI1 via ubiquitination in osteoblasts |
| Q47710981 | Neuropeptide Y Y2 antagonist treated ovariectomized mice exhibit greater bone mineral density. |
| Q38070913 | New developments in the area of factor XIII. |
| Q39321670 | Novel curcumin analogue UBS109 potently stimulates osteoblastogenesis and suppresses osteoclastogenesis: involvement in Smad activation and NF-κB inhibition. |
| Q38205860 | Novel techniques in the development of osteoporosis drug therapy: the osteoclast ruffled-border vacuolar H(+)-ATPase as an emerging target |
| Q37938914 | Nutrition, bone, and aging: an integrative physiology approach |
| Q91863478 | OPG/RANK/RANKL signaling axis in patients with type I diabetes: Associations with parathormone and vitamin D |
| Q60953221 | Obesity attenuates force-induced tooth movement in mice with the elevation of leptin level: a preliminary translational study |
| Q36588344 | On a new law of bone remodeling based on damage elasticity: a thermodynamic approach |
| Q92239689 | Oral Administrations of Hancornia speciosa Gomes Latex Do Not Increase Bone Neoformation |
| Q65556502 | Organotropic drug delivery: Synthetic nanoparticles and extracellular vesicles |
| Q46294640 | Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model |
| Q45367210 | Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss. |
| Q36556173 | Osteoclasts Are Required for Hematopoietic Stem and Progenitor Cell Mobilization but Not for Stress Erythropoiesis in Plasmodium chabaudi adami Murine Malaria |
| Q38230277 | Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles? |
| Q54976691 | Osteocytes Specific GSK3 Inhibition Affects In Vitro Osteogenic Differentiation. |
| Q60123135 | Osteocytes are not only mechanoreceptive cells |
| Q59792176 | Osteogenic Induction of Wharton's Jelly-Derived Mesenchymal Stem Cell for Bone Regeneration: A Systematic Review |
| Q90729095 | Osteoporosis: Mechanism, Molecular Target, and Current Status on Drug Development |
| Q31122856 | Oyster Shell Proteins Originate from Multiple Organs and Their Probable Transport Pathway to the Shell Formation Front |
| Q99557259 | PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast-osteoblast uncoupling |
| Q33717803 | PPARD is an Inhibitor of Cartilage Growth in External Ears |
| Q57109145 | PTH1R-CaSR Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases |
| Q41970922 | Palmitoleic Acid Inhibits RANKL-Induced Osteoclastogenesis and Bone Resorption by Suppressing NF-κB and MAPK Signalling Pathways |
| Q52601534 | Parathyroid hormone-induced down-regulation of miR-532-5p for matrix metalloproteinase-13 expression in rat osteoblasts. |
| Q35697027 | Phospholipase Cγ2 is required for basal but not oestrogen deficiency-induced bone resorption. |
| Q30997344 | Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics. |
| Q64953898 | Platelet-rich fibrin increases the osteoprotegerin/receptor activator of nuclear factor-κB ligand ratio in osteoblasts. |
| Q36106270 | Porcine placenta hydrolysates enhance osteoblast differentiation through their antioxidant activity and effects on ER stress |
| Q36085402 | Porcine placenta hydrolysates regulate calcium disturbance in MC3T3-E1 osteoblastic cells |
| Q37958733 | Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms. |
| Q47632345 | Potential role of rebamipide in osteoclast differentiation and mandibular condylar cartilage homeostasis |
| Q57566244 | Premature loss of bone remodeling compartment canopies is associated with deficient bone formation: A study of healthy individuals and patients with cushing's syndrome |
| Q64890306 | Putative Effects of Nutritive Polyphenols on Bone Metabolism In Vivo-Evidence from Human Studies. |
| Q34209272 | RANK, RANKL and OPG Expression in Breast Cancer - Influence on Osseous Metastasis |
| Q50877224 | Rad GTPase is essential for the regulation of bone density and bone marrow adipose tissue in mice. |
| Q88923210 | Radium-223 Dichloride in Combination with Vascular Endothelial Growth Factor-Targeting Therapy in Advanced Renal Cell Carcinoma with Bone Metastases |
| Q28066355 | Rapid phenotyping of knockout mice to identify genetic determinants of bone strength |
| Q89419511 | Regulation of Breast Cancer-Induced Osteoclastogenesis by MacroH2A1.2 Involving EZH2-Mediated H3K27me3 |
| Q64069924 | Regulation of Osteoclast Differentiation and Skeletal Maintenance by Histone Deacetylases |
| Q37022898 | Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1. |
| Q47931212 | Resveratrol suppresses the alveolar bone resorption induced by artificial trauma from occlusion in mice. |
| Q39607279 | Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells |
| Q58566593 | Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy |
| Q37729929 | Role of Protein Phosphatase 2A in Osteoblast Differentiation and Function |
| Q36773018 | Role of Thyroid Hormones in Skeletal Development and Bone Maintenance |
| Q35991793 | Role of carotenoid β-cryptoxanthin in bone homeostasis |
| Q91782570 | S1P-S1PR1 Signaling: the "Sphinx" in Osteoimmunology |
| Q34313964 | Scavenger receptor-A (CD204): a two-edged sword in health and disease |
| Q48368979 | Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro-tumourigenic 'activated' state that enhances prostate cancer cell migration. |
| Q38837102 | Selective regulation of Mmp13 by 1,25(OH)2D3, PTH, and Osterix through distal enhancers. |
| Q50188819 | Selective regulation of osteoclast adhesion and spreading by PLCγ/PKCα-PKCδ/RhoA-Rac1 signaling |
| Q35665655 | Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development |
| Q96303393 | Self-healing capacity of fiber-reinforced calcium phosphate cements |
| Q37687000 | Sex-specific autophagy modulation in osteoblastic lineage: a critical function to counteract bone loss in female |
| Q41983127 | Sodium Nitroprusside Changed The Metabolism of Mesenchymal Stem Cells to An Anaerobic State while Viability and Proliferation Remained Intact |
| Q38736047 | Stem cells applications in bone and tooth repair and regeneration: New insights, tools, and hopes |
| Q33619640 | Stress and Alterations in Bones: An Interdisciplinary Perspective |
| Q96305153 | Strontium-substituted sub-micron bioactive glasses inhibit ostoclastogenesis through suppression of RANKL-induced signaling pathway |
| Q55313392 | Substance P modulates bone remodeling properties of murine osteoblasts and osteoclasts. |
| Q33766770 | Succinate and its G-protein-coupled receptor stimulates osteoclastogenesis. |
| Q48209434 | Syringic acid, a phenolic acid, promotes osteoblast differentiation by stimulation of Runx2 expression and targeting of Smad7 by miR-21 in mouse mesenchymal stem cells |
| Q35097782 | Systemic infusion of mesenchymal stem cells improves cell-based bone regeneration via upregulation of regulatory T cells |
| Q37066493 | TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis |
| Q38970585 | Targeting the Bone Marrow Microenvironment. |
| Q90216390 | The Antagonist of Retinoic Acid Receptor α, ER-50891 Antagonizes the Inhibitive Effect of All-Trans Retinoic Acid and Rescues Bone Morphogenetic Protein 2-Induced Osteoblastogenic Differentiation |
| Q92712185 | The Autophagy in Osteoimmonology: Self-Eating, Maintenance, and Beyond |
| Q92081389 | The Bone Extracellular Matrix as an Ideal Milieu for Cancer Cell Metastases |
| Q47224539 | The Components of Bone and What They Can Teach Us about Regeneration |
| Q35674722 | The Effect of OSM on MC3T3-E1 Osteoblastic Cells in Simulated Microgravity with Radiation |
| Q37352889 | The Effects of Dietary Supplements of Calcium, Vitamin D and Estrogen Hormone on Serum Levels of OPG and RANKL Cytokines and their Relationship with Increased Bone Density in Rats. |
| Q88907245 | The Growth Proliferation, Apoptotic Prevention, and Differentiation Induction of the Gelatin Hydrolysates from Three Sources to Human Fetal Osteoblasts (hFOB 1.19 Cells) |
| Q97557237 | The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management |
| Q53211469 | The Protective Effects of Alisol A 24-Acetate from Alisma canaliculatum on Ovariectomy Induced Bone Loss in Vivo. |
| Q26783615 | The Role of Hedgehog Signaling in Tumor Induced Bone Disease |
| Q39120074 | The Role of TGFβ in Bone-Muscle Crosstalk |
| Q38940135 | The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases |
| Q38545213 | The dynamic skeleton |
| Q46851946 | The effect of etidronate on the periodontium of ovariectomized rats |
| Q33918020 | The effects of proteasome inhibitors on bone remodeling in multiple myeloma |
| Q88815672 | The impact of age on radium-223 distribution and an evaluation of molecular imaging surrogates |
| Q36007649 | The influence of calcitonin gene-related peptide on markers of bone metabolism in MG-63 osteoblast-like cells co-cultured with THP-1 macrophage-like cells under virtually osteolytic conditions |
| Q41683326 | The inhibitors of cyclin-dependent kinases and GSK-3β enhance osteoclastogenesis |
| Q35583735 | The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice |
| Q33875419 | The p38α MAPK function in osteoprecursors is required for bone formation and bone homeostasis in adult mice |
| Q51790755 | The p38α MAPK positively regulates osteoblast function and postnatal bone acquisition. |
| Q33565236 | The role of DNA methylation in common skeletal disorders |
| Q36111285 | The role of RANK ligand/osteoprotegerin in rheumatoid arthritis |
| Q37585395 | The role of midkine in skeletal remodelling |
| Q38181384 | The role of regucalcin in bone homeostasis: involvement as a novel cytokine |
| Q38602606 | Thyroid diseases and bone health |
| Q89107012 | Tissue engineered bone mimetics to study bone disorders ex vivo: Role of bioinspired materials |
| Q30725567 | Total water, phosphorus relaxation and inter-atomic organic to inorganic interface are new determinants of trabecular bone integrity |
| Q47219376 | Trabecular mapping: Leveraging geometric morphometrics for analyses of trabecular structure |
| Q50104779 | Transforming growth factor-β in stem cells and tissue homeostasis |
| Q57462447 | Ubiquitin-specific protease USP34 controls osteogenic differentiation and bone formation by regulating BMP2 signaling |
| Q48198849 | Upconversion Nanocarriers Encapsulated with Photoactivatable Ru Complexes for Near-Infrared Light-Regulated Enzyme Activity |
| Q93196080 | Uptake of osteoblast-derived extracellular vesicles promotes the differentiation of osteoclasts in the zebrafish scale |
| Q38648767 | Ursolic Acid--A Pentacyclic Triterpenoid with a Wide Spectrum of Pharmacological Activities |
| Q64282246 | Vitamin A decreases the anabolic bone response to mechanical loading by suppressing bone formation |
| Q37582330 | β-Caryophyllene promotes osteoblastic mineralization, and suppresses osteoclastogenesis and adipogenesis in mouse bone marrow cultures in vitro |
Search more.